Education
About Us
Working with TipRanks
Follow Us
Organogenesis Holdings Inc (ORGO)
NASDAQ:ORGO
Earnings Data
Report Date
Aug 06, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.04Last Year’s EPS
-0.13Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 08, 2025
|% Change Since: -42.32%
|Next Earnings Date:Aug 06, 2025
Earnings Call Sentiment|Neutral
The earnings call reflects a challenging quarter for Organogenesis, marked by significant revenue declines and increased losses due to disruptions from LCD implementation delays. However, the reaffirmed revenue guidance, growth in Surgical and Sports Medicine, and strategic advancements in product development and manufacturing highlight potential for future recovery and growth.Company Guidance
During the first quarter 2025 earnings call, Organogenesis Holdings Inc. reaffirmed their financial guidance for the year, projecting net revenue between $480 million and $535 million, with anticipated growth ranging from flat to an 11% increase year-over-year. The company reported a Q1 net revenue of $86.7 million, reflecting a 21% decline, aligning with their prior guidance of $85 to $95 million. Advanced Wound Care products contributed $79.9 million, a 23% decrease, while Surgical and Sports Medicine products reported an 11% increase, totaling $6.8 million. The gross margin for the quarter was 72.6%, slightly down from last year's 73.9%, impacted by lower revenue and product expiration due to a delayed LCD implementation. Operating expenses increased by 5% to $89.7 million, influenced by a $6.6 million asset write-down, partially offset by a 17% reduction in R&D expenses. The call highlighted the company's strategic focus on leveraging its diverse product portfolio and customer relationships to navigate market challenges, particularly in light of CMS's delay in LCD implementation to 2026, which Organogenesis supports as an opportunity to review coverage policies and submit additional evidence for product coverage.Surgical and Sports Medicine Revenue Growth
Net revenue from Surgical and Sports Medicine products for the first quarter was $6.8 million, up 11% year-over-year.
Strong Financial Position
The company had $110.5 million in cash, cash equivalents, and restricted cash with no outstanding debt obligations as of 03/31/2025.
Reaffirmed 2025 Revenue Guidance
The company reaffirmed its net revenue guidance for 2025 of between $480 million and $535 million, representing a year-over-year change in the range of roughly flat to an increase of 11%.
Development and Submission Progress
Organogenesis is on track to submit additional clinical and real-world evidence to CMS and plans to submit a BLA for RENEW by the end of the year.
Expansion of Manufacturing Capabilities
Significant progress in expanding manufacturing capabilities with a new facility in Smithfield, Rhode Island, to support new product introductions and reintroductions.
---
ORGO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
ORGO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 08, 2025 | $5.34 | $3.06 | -42.70% |
Feb 27, 2025 | $3.07 | $6.21 | +102.28% |
Nov 12, 2024 | $3.45 | $4.43 | +28.41% |
Aug 08, 2024 | $2.62 | $2.55 | -2.67% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Organogenesis Holdings Inc (ORGO) report earnings?
Organogenesis Holdings Inc (ORGO) is schdueled to report earning on Aug 06, 2025, TBA Not Confirmed.
What is Organogenesis Holdings Inc (ORGO) earnings time?
Organogenesis Holdings Inc (ORGO) earnings time is at Aug 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ORGO EPS forecast?
ORGO EPS forecast for the fiscal quarter 2025 (Q2) is -0.04.
---